The Trajectory of Antibody Responses One Year Following SARS-CoV-2 Infection among Indigenous Individuals in the Southwest United States
Viruses · 2024
DOI: 10.3390/v16101573 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Claire P Smith und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. Hauptthemen laut MEDLINE: COVID-19, Antibodies, Viral, SARS-CoV-2, Spike Glycoprotein, Coronavirus. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, CDC HHS, Centers for Disease Control and Prevention.
Abstract (Originalsprache)
SARS-CoV-2 antibody kinetics based on immunologic history is not fully understood. We analyzed anti-spike and anti-nucleocapsid antibody responses following acute infection in a cohort of Indigenous persons. The models of peak concentrations and decay rates estimated that one year after infection, participants would serorevert for anti-nucleocapsid antibodies and remain seropositive for anti-spike antibodies. The peak anti-spike concentrations were higher for individuals vaccinated prior to infection, but the decay rates were similar across immunologic status groups. Children had significantly lower peak anti-spike concentrations than adults. This study affirms the importance of continued vaccination to maintain high levels of immunity in the face of waning immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
- Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
- Department of Medicine, Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.
- Division of Coronaviruses and Other Respiratory Viruses, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
ORCID-Profile: Claire P Smith, Rachel M Hartman, Owen R Baker, Tarayn A Fairlie, Oliver Laeyendecker, Catherine G Sutcliffe
Förderung
- NIAID NIH HHS
- CDC HHS
- Centers for Disease Control and Prevention
Zitieren
APA
Smith, C. P., Hartman, R. M., Kugler, A. M., Little, V., Baker, O. R., Fairlie, T. A., Fernandez, R. E., Hagen, M. B., Honie, E., Laeyendecker, O., Midgley, C. M., Parker, D., Sandoval, M., Takahashi, S., Hammitt, L. L., & Sutcliffe, C. G. (2024). The Trajectory of Antibody Responses One Year Following SARS-CoV-2 Infection among Indigenous Individuals in the Southwest United States. Viruses. https://doi.org/10.3390/v16101573
Vancouver
Smith CP, Hartman RM, Kugler AM, Little V, Baker OR, Fairlie TA, et al. The Trajectory of Antibody Responses One Year Following SARS-CoV-2 Infection among Indigenous Individuals in the Southwest United States. Viruses. 2024. doi:10.3390/v16101573
BibTeX
@article{Smith2024,
author = {Smith, Claire P and Hartman, Rachel M and Kugler, Alexa M and Little, Verlena and Baker, Owen R and Fairlie, Tarayn A and Fernandez, Reinaldo E and Hagen, Melissa B and Honie, Elvira and Laeyendecker, Oliver and Midgley, Claire M and Parker, Dennie and Sandoval, Marqia and Takahashi, Saki and Hammitt, Laura L and Sutcliffe, Catherine G},
title = {The Trajectory of Antibody Responses One Year Following SARS-CoV-2 Infection among Indigenous Individuals in the Southwest United States},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16101573}
}
EUVIMED